Author

P. Proost

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:differential expression· 1

Frequent Co-Authors

E. Martens· 2 shared N. Berghmans· 2 shared A. C. G. Salina· 1 shared A. De Zutter· 1 shared A. Fabro· 1 shared A. Quadros· 1 shared A. Schneider· 1 shared B. Cauwe· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Martens

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

C-terminal truncation of CXCL10 attenuates inflammatory activity but retains angiostatic properties

L. Dillemans, K. Yu, A. De Zutter, S. Noppen, M. Gouwy, N. Berghmans, M. De Bondt, L. Vanbrabant, S. Brusselmans, E. Martens, D. Schols, P. E. Marques, S. Struyf, P. Proost

This study shows that truncating the C-terminus of CXCL10 reduces its inflammatory activity but maintains its anti-angiogenic effects.

bioRxiv · Jul 10, 2023 · PreprintImmunology

Targeting C5aR1 signaling reduced neutrophil extracellular traps and ameliorates COVID-19 pathology

B. M. Silva, F. P. Veras, G. Gomes, S. Cambier, G. Silva, A. Quadros, D. Caetite, D. Nascimento, C. Silva, J. Silva, S. Damasceno, A. Schneider, F. Beretta, S. Batah, I. Castro, , T. M. Cunha

This study shows that inhibiting C5aR1 signaling reduces neutrophil extracellular traps and improves lung pathology in COVID-19.

bioRxiv · Jul 3, 2022Immunology

Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis

E. U. Berzal, N. Berghmans, L. Boon, E. Martens, J. Vandooren, B. Cauwe, G. Thijs, P. Proost, J. Van Damme, G. Opdenakker

This study investigates the role of MMP-9 in EAE, showing it acts independently of Fas and has phase-specific effects on disease progression and immune activation.

bioRxiv · May 14, 2018Immunology